Amgen Phase II pegfilgrastim data

In a Phase II study of 60 non-Hodgkin's lymphoma or Hodgkin's disease patients receiving chemotherapy, a single injection of pegfilgrastim, a pegylated formulation of AMGN's Neupogen, met the primary ...